Integrated Biopharma Market Risk Adjusted Performance

INBP Stock  USD 0.30  0.00  0.00%   
Integrated Biopharma market risk adjusted performance lookup summarizes this and related technical indicators for Integrated Biopharma. Data availability can vary by region and feed; Equity Screeners provides broader screening access. Integrated Biopharma has a market cap of 11.2 M, operating margin of 2.67%, ROE of 12.68%. Use Risk vs Return Analysis to explore allocation context. This includes a position in Integrated Biopharma inside the allocation mix. Also, note that the market value of any otc stock could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
  
Integrated Biopharma has current Market Risk Adjusted Performance of 0.0361.

MRAP

 = 

ER[a] + (1/BETA - 1)

X

ER[a] - RFR)

 = 
0.0361
ER[a] = Expected return on investing in Integrated Biopharma
RFR = Risk Free Rate of return. Typically T-Bill Rate
BETA = Beta of the asset with market or selected benchmark.

Integrated Biopharma Market Risk Adjusted Performance Peers Comparison

Integrated Market Risk Adjusted Performance Relative To Other Indicators

Integrated Biopharma is ranked fourth for market risk adjusted performance against industry peers. It is currently under evaluation for maximum drawdown against industry peers with Maximum Drawdown measuring nearly 519.39 against Market Risk Adjusted Performance. Maximum Drawdown runs about 519.39 times Market Risk Adjusted Performance for Integrated Biopharma
Compare Integrated Biopharma to Peers

Thematic Opportunities

Explore Investment Opportunities

Build portfolios using Macroaxis predefined set of investing ideas. Many of Macroaxis investing ideas can easily outperform a given market. Ideas can also be optimized per your risk profile before portfolio origination is invoked. Macroaxis thematic optimization helps investors identify companies most likely to benefit from changes or shifts in various micro-economic or local macro-level trends. Originating optimal thematic portfolios involves aligning investors' personal views, ideas, and beliefs with their actual investments.
Explore Investing Ideas